110PCellMiner and CellMiner cross-database (CDB): Resources for the exploration of pharmacogenomics using cancerous cell-lines

Background: Determining the influence of molecular alterations on pharmacological responses in cancer cell lines from the omic perspective is the logical first step towards making oncology treatment for patients more effective, specific, and targeted. Our established CellMiner (and in development CellMinerCDB (https://discover.nci.nih.gov/cellminercdb/) web-applications provide high-quality, clean, and numerically extensive molecular and pharmacological data for these purposes.